CX3CR1 and pancreatic neoplasm: This associates with an upregulated expression of the CX3CL1 receptor, CX3CR1, in pancreatic cancer specimen [23] and therefore our array analysis prompted us to investigate whether the TRAIL-NF-κB mediated CX3CL1 expression directly affects the apoptosis resistance of PDAC cells.